140 related articles for article (PubMed ID: 26529120)
1. Potent Human Telomerase Inhibitors: Molecular Dynamic Simulations, Multiple Pharmacophore-Based Virtual Screening, and Biochemical Assays.
Shirgahi Talari F; Bagherzadeh K; Golestanian S; Jarstfer M; Amanlou M
J Chem Inf Model; 2015 Dec; 55(12):2596-610. PubMed ID: 26529120
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of new benzimidazole-carbazole conjugates for the stabilization of human telomeric DNA, telomerase inhibition, and their selective action on cancer cells.
Maji B; Kumar K; Kaulage M; Muniyappa K; Bhattacharya S
J Med Chem; 2014 Aug; 57(16):6973-88. PubMed ID: 25062468
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis and Molecular Docking Analysis of Flavonoid Derivatives as Potential Telomerase Inhibitors.
Fan ZF; Ho ST; Wen R; Fu Y; Zhang L; Wang J; Hu C; Shaw PC; Liu Y; Cheng MS
Molecules; 2019 Sep; 24(17):. PubMed ID: 31480619
[TBL] [Abstract][Full Text] [Related]
4. Homology Model and Docking-Based Virtual Screening for Ligands of Human Dyskerin as New Inhibitors of Telomerase for Cancer Treatment.
Armando RG; Mengual Gómez DL; Juritz EI; Lorenzano Menna P; Gomez DE
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30340325
[TBL] [Abstract][Full Text] [Related]
5. New Genetic Bomb Trigger: Design, Synthesis, Molecular Dynamics Simulation, and Biological Evaluation of Novel BIBR1532-Related Analogs Targeting Telomerase against Non-Small Cell Lung Cancer.
Tawfik HO; El-Hamaky AA; El-Bastawissy EA; Shcherbakov KA; Veselovsky AV; Gladilina YA; Zhdanov DD; El-Hamamsy MH
Pharmaceuticals (Basel); 2022 Apr; 15(4):. PubMed ID: 35455478
[TBL] [Abstract][Full Text] [Related]
6. Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA.
Maji B; Bhattacharya S
Chem Commun (Camb); 2014 Jun; 50(49):6422-38. PubMed ID: 24695755
[TBL] [Abstract][Full Text] [Related]
7. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay.
Gomez D; Mergny JL; Riou JF
Cancer Res; 2002 Jun; 62(12):3365-8. PubMed ID: 12067975
[TBL] [Abstract][Full Text] [Related]
8. Screening of telomerase inhibitors.
Kleideiter E; Piotrowska K; Klotz U
Methods Mol Biol; 2007; 405():167-80. PubMed ID: 18369824
[TBL] [Abstract][Full Text] [Related]
9. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biophysical and biological evaluation of 3,6-bis-amidoacridines with extended 9-anilino substituents as potent G-quadruplex-binding telomerase inhibitors.
Schultes CM; Guyen B; Cuesta J; Neidle S
Bioorg Med Chem Lett; 2004 Aug; 14(16):4347-51. PubMed ID: 15261300
[TBL] [Abstract][Full Text] [Related]
11. A new insight into mushroom tyrosinase inhibitors: docking, pharmacophore-based virtual screening, and molecular modeling studies.
Bagherzadeh K; Shirgahi Talari F; Sharifi A; Ganjali MR; Saboury AA; Amanlou M
J Biomol Struct Dyn; 2015; 33(3):487-501. PubMed ID: 24601849
[TBL] [Abstract][Full Text] [Related]
12. New prospects for targeting telomerase beyond the telomere.
Arndt GM; MacKenzie KL
Nat Rev Cancer; 2016 Aug; 16(8):508-24. PubMed ID: 27339602
[TBL] [Abstract][Full Text] [Related]
13. Structural Basis of Telomerase Inhibition by the Highly Specific BIBR1532.
Bryan C; Rice C; Hoffman H; Harkisheimer M; Sweeney M; Skordalakes E
Structure; 2015 Oct; 23(10):1934-1942. PubMed ID: 26365799
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of human telomeric G-quadruplex and inhibition of telomerase activity by propeller-shaped trinuclear Pt(II) complexes.
Xu CX; Shen Y; Hu Q; Zheng YX; Cao Q; Qin PZ; Zhao Y; Ji LN; Mao ZW
Chem Asian J; 2014 Sep; 9(9):2519-26. PubMed ID: 24996049
[TBL] [Abstract][Full Text] [Related]
15. Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo.
Wang Y; Cheng FX; Yuan XL; Tang WJ; Shi JB; Liao CZ; Liu XH
Eur J Med Chem; 2016 Apr; 112():231-251. PubMed ID: 26900656
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation, 3D-QSAR studies of novel aryl-2H-pyrazole derivatives as telomerase inhibitors.
Luo Y; Zhang S; Qiu KM; Liu ZJ; Yang YS; Fu J; Zhong WQ; Zhu HL
Bioorg Med Chem Lett; 2013 Feb; 23(4):1091-5. PubMed ID: 23312949
[TBL] [Abstract][Full Text] [Related]
17. Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
Dominick PK; Keppler BR; Legassie JD; Moon IK; Jarstfer MB
Bioorg Med Chem Lett; 2004 Jul; 14(13):3467-71. PubMed ID: 15177454
[TBL] [Abstract][Full Text] [Related]
18. Telomerase inhibition and telomere targeting in hematopoietic cancer cell lines with small non-nucleosidic synthetic compounds (BIBR1532).
El Daly H; Martens UM
Methods Mol Biol; 2007; 405():47-60. PubMed ID: 18369817
[TBL] [Abstract][Full Text] [Related]
19. The addition of a spin column step in the telomeric repeat application protocol removes telomerase inhibitors.
Chen YC; Huang FC; Lin JJ
Anal Biochem; 2015 Jun; 478():49-51. PubMed ID: 25813207
[TBL] [Abstract][Full Text] [Related]
20. TRAP-LIG, a modified telomere repeat amplification protocol assay to quantitate telomerase inhibition by small molecules.
Reed J; Gunaratnam M; Beltran M; Reszka AP; Vilar R; Neidle S
Anal Biochem; 2008 Sep; 380(1):99-105. PubMed ID: 18534183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
